Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer

Acta Oncologica

Volumn 39, Issue 4, 2000, Pages 519-522

  Gerl, Arthur ^a   Schierl, Rudolf ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PLATINUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EXCRETION; DRUG HALF LIFE; DRUG URINE LEVEL; HUMAN; MALE; POTENTIOMETRY; PRIORITY JOURNAL; TESTIS CANCER;

EID: 0033799482     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600750013447     Document Type: Article

References (21)

1. Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer
2. Testicular germ-cell cancer
3. Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: A single-institution experience
4. Evaluation of long-term toxicity after chemotherapy for testicular cancer
5. Is cisplatin a human carcinogen?
6. The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy
7. Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs
8. Long-term platinum excretion in patients treated with cisplatin
9. Platinum concentration in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum (II)
10. Cisplatin based chemotherapy in testicular cancer patients: Long-term platinum excretion and clinical effects
11. Urinary excretion of platinum from platinum industry workers
12. Human tissue distribution of platinum after cis-diamminedichloroplatinum
13. Distribution of platinum in patients treated with cisplatin determined by radiochemical neutron activation analysis
14. Endocrinological late effects after chemotherapy for testicular cancer
15. The impact of chemotherapy on Leydig cell function (LCF) in long-term survivors of germ cell tumors (GCT)
16. Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer
17. Hypercholesterolemia after chemotherapy for testis cancer
18. The impact of chemotherapy on fasting plasma lipids in patients with germ cell tumors (GCT)
19. Risk of second malignant neoplasms among long-term survivors of testicular cancer
20. Risk of leukemia after platinum-based chemotherapy for ovarian cancer